Abstract:Pancreatic cancer is a devastating disease with a high mortality rate and a lack of effective therapies. The challenges associated with early detection and the highly aggressive nature of pancreatic cancer have limited treatment options, underscoring the urgent need for better disease-modifying therapies. Peptide-based biotherapeutics have become an attractive area of research due to their favorable properties such as high selectivity and affinity, chemical modifiability, good tissue permeability, and easy metabolism and excretion. Phage display, a powerful technique for identifying peptides with high affinity and specificity for their target molecules, has emerged as a key tool in the discovery of peptide-based drugs. Phage display technology involves the use of bacteriophages to express peptide libraries, which are then screened against a target of interest to identify peptides with desired properties. This approach has shown great promise in cancer diagnosis and treatment, with potential applications in targeting cancer cells and developing new therapies. In this comprehensive review, we provide an overview of the basic biology of phage vectors, the principles of phage library construction, and various methods for binding affinity assessment. We then describe the applications of phage display in pancreatic cancer therapy, targeted drug delivery, and early detection. Despite its promising potential, there are still challenges to be addressed, such as optimizing the selection process and improving the pharmacokinetic properties of phage-based drugs. Nevertheless, phage display represents a promising approach for the development of novel targeted therapies in pancreatic cancer and other tumors. Graphical abstract

Phage Display Peptide Library Technology's Application in the Diagnosis and Therapy of Tumor

Phage Display Technology and Its Applications for Tumor Research

Phage Display Technology and Its Applications in Cancer Immunotherapy

Guiding nanomaterials to tumors for breast cancer precision medicine: from tumor-targeting small-molecule discovery to targeted nanodrug delivery.

Phage display screening of therapeutic peptide for cancer targeting and therapy

Molecular addresses of tumors: selection by in vivo phage display

Generation of peptides using phage display technology for cancer diagnosis and molecular imaging

Phage display applications for molecular imaging.

Specific Phage-Displayed Peptides Binding to Tumor Vasculature

[Phage antibody library technology in tumor therapy: a review].

Panning and Identification of a Colon Tumor Binding Peptide from a Phage Display Peptide Library

Phage-based peptides for pancreatic cancer diagnosis and treatment: alternative approach

Advancement and applications of peptide phage display technology in biomedical science

Tumor-Targeting Peptides Search Strategy for the Delivery of Therapeutic and Diagnostic Molecules to Tumor Cells

Construct breast carcinoma T7 phage display cDNA library

Phage Nanofibers in Nanomedicine: Biopanning for Early Diagnosis, Targeted Therapy, and Proteomics Analysis

Selection technology of phage antibody library and its application in tumor research

Phage Display-Based Nanotechnology Applications in Cancer Immunotherapy

Phage Display Technology and Its Application

Advance and Application of Phage Display Techniques

Tumor-Targeting Peptides: Ligands for Molecular Imaging and Therapy